| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.17 | 0.005 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.006 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |